By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


TaiGen Biotechnology 

Nei-Hu  Taipei    Taiwan
Phone: N/A Fax:



Start Up

Company News
TaiGen Biotechnology Submits NDA In China For Novel IV Antibiotic 5/31/2017 1:16:50 PM
TaiGen Biotechnology Announces Submission Of New Drug Application For Taigexyn Intravenous Formulation To The China Food And Drug Administration 5/30/2017 6:24:39 AM
TaiGen Biotechnology And HEC Pharmaceutical Executed Equity Purchase Agreement For Their HCV Joint Venture 3/27/2017 6:44:56 AM
TaiGen Biotechnology To Establish A New Company With HEC Pharmaceutical In China For Treatment Of Chronic Hepatitis C 10/31/2016 7:22:26 AM
TaiGen Biotechnology Out-Licenses Taigexyn (Nemonoxacin) To Productos Científicos For The Latin American Market 8/25/2016 7:15:23 AM
TaiGen Biotechnology Receives Market Approval From The China Food And Drug Administration For Taigexyn (Nemonoxacin) 6/14/2016 12:41:10 PM
TaiGen Biotechnology Launches Taigexyn In Taiwan 12/16/2015 6:22:06 AM
TaiGen Biotechnology's Intravenous Taigexyn Successfully Achieved Primary Endpoint In Phase 3 Clinical Trial For Community Acquired Pneumonia 12/3/2015 6:27:20 AM
TaiGen Biotechnology Starts China Trial Of Novel Chemotherapy Sensitizer 5/1/2015 11:09:40 AM
TaiGen Biotechnology Announces Initiation of Burixafor Chemosensitization Clinical Trial In Acute Myeloid Leukemia In China 4/30/2015 6:21:40 AM